We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — Data from a 7-year clinical study of the ...
Please provide your email address to receive an email when new articles are posted on . Six years of treatment reduced axial growth by 0.52 mm, while 3 years of treatment reduced growth by 0.19 mm.
Becomes the First and Only FDA Approved Contact Lens of its Kind in the U.S. SAN RAMON, Calif., Nov. 18, 2019 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), announced today that CooperVision has ...
MiSight® 1 day is approved for myopia control in more than 40 countries around the world, and is the first and only soft ...
SAN RAMON, Calif., Oct. 9, 2020 /PRNewswire/ -- CooperVision is reporting the latest findings from its landmark MiSight® 1 day clinical study, providing new insights about myopia management and the ...
In the study’s seventh year, participants were transitioned from MiSight ® 1 day to a single vision contact lens to evaluate if treatment gains would be retained. Myopic progression then occurred only ...
SAN RAMON, CALIF., March 10, 2022—A new peer review paper affirms that CooperVision ® MiSight ® 1 day contact lenses provide myopia control for nearly all children. †1 In the longest-running soft ...
SAN RAMON, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that the Chinese National Medical Products Administration (NMPA), which regulates medical devices and ...
Hosted on MSN
Cooper Companies outlines $2B free cash flow target over next 3 years while advancing MyDAY and MiSight launches
Andrews provided Q4 consolidated revenue guidance of $1.049 billion to $1.069 billion, representing 2% to 4% organic growth. CooperVision's revenue is expected to be in the range of $700 million to ...
CooperVision announced it has received U.S. Food and Drug Administration (FDA) approval on Nov. 15, 2019 of its innovative MiSight ® 1 day contact lens. The cornerstone of a comprehensive myopia ...
The Cooper Companies, Inc.’s COO growth is fueled by CooperVision’s premium lens migration and MiSight’s myopia-management leadership, supported by CooperSurgical’s women’s health and fertility ...
ROCHESTER, N.Y., Feb. 10, 2026 /PRNewswire/ -- CooperVision today announced immediate availability of its MiSight ® 1 day * myopia control contact lens in Japan, where as many as 77% of elementary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results